Efficacy and safety of perilesional/intralesional triamcinolone injections in oral mucous membrane pemphigoid

Br J Dermatol. 2016 Feb;174(2):436-8. doi: 10.1111/bjd.14043. Epub 2015 Nov 21.

Authors

A Kalinska-Bienias¹, M Kalowska², B Kwiek², B Jakubowska², N Ishii³, T Hashimoto³, C Kowalewski², K Wozniak²

Affiliations

¹ Department of Dermatology and Immunodermatology, Medical University of Warsaw, Str. Koszykowa 82a, 02-008, Warsaw, Poland. [email protected].
² Department of Dermatology and Immunodermatology, Medical University of Warsaw, Str. Koszykowa 82a, 02-008, Warsaw, Poland.
³ Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan.

PMID: 26211496
DOI: 10.1111/bjd.14043

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Inflammatory Agents / administration & dosage*
Anti-Inflammatory Agents / adverse effects
Female
Humans
Injections, Intralesional
Mouth Diseases / drug therapy*
Pemphigoid, Benign Mucous Membrane / drug therapy*
Treatment Outcome
Triamcinolone / administration & dosage*
Triamcinolone / adverse effects

Substances

Anti-Inflammatory Agents
Triamcinolone